drugset / Trial / NCT01025245

Effect of Intraoperative Magnesium on Remifentanil-induced Postoperative Hyperalgesia After Thyroidectomy

NCT01025245

Phase 4 Completed 84 enrolled Yonsei University
Parallel-groupOpen-labelPrevention

Summary

The purpose of this study is to study the effect of intraoperative magnesium on remifentanil-induced postoperative hyperalgesia after thyroidectomy

Timeline

Start
2009-11
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 10 mg/kg Intravenous
Subject Remifentanil Small molecule 0.05 ug/kg
Subject Remifentanil Small molecule 0.2 ug/kg

Indications

No indication recorded.